

Publisher: Bentham Science Publishers
E-ISSN: 1875-5607|2|3|201-208
ISSN: 1389-5575
Source: Mini Reviews in Medicinal Chemistry, Vol.2, Iss.3, 2002-06, pp. : 201-208
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Pyrrolo[2,3-d]pyrimidines as inhibitors of pp60c-src
Expert Opinion on Therapeutic Patents, Vol. 7, Iss. 3, 1997-03 ,pp. :








Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors
Current Medicinal Chemistry, Vol. 18, Iss. 7, 2011-03 ,pp. :